Global IVD Infectious Disease Market Insights and Forecast to 2028

Report ID: 1565436 | Published Date: Oct 2024 | No. of Page: 113 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global IVD Infectious Disease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biochemical Diagnosis
        1.2.3 Immune Diagnosis
        1.2.4 Molecular Diagnosis
        1.2.5 Microbiological Diagnosis
        1.2.6 Urine Diagnosis
        1.2.7 Coagulation Diagnosis
        1.2.8 Other
    1.3 Market by Application
        1.3.1 Global IVD Infectious Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Personal
        1.3.3 Commercial
        1.3.4 Academic
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global IVD Infectious Disease Market Perspective (2017-2028)
    2.2 IVD Infectious Disease Growth Trends by Region
        2.2.1 IVD Infectious Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 IVD Infectious Disease Historic Market Size by Region (2017-2022)
        2.2.3 IVD Infectious Disease Forecasted Market Size by Region (2023-2028)
    2.3 IVD Infectious Disease Market Dynamics
        2.3.1 IVD Infectious Disease Industry Trends
        2.3.2 IVD Infectious Disease Market Drivers
        2.3.3 IVD Infectious Disease Market Challenges
        2.3.4 IVD Infectious Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top IVD Infectious Disease Players by Revenue
        3.1.1 Global Top IVD Infectious Disease Players by Revenue (2017-2022)
        3.1.2 Global IVD Infectious Disease Revenue Market Share by Players (2017-2022)
    3.2 Global IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by IVD Infectious Disease Revenue
    3.4 Global IVD Infectious Disease Market Concentration Ratio
        3.4.1 Global IVD Infectious Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Disease Revenue in 2021
    3.5 IVD Infectious Disease Key Players Head office and Area Served
    3.6 Key Players IVD Infectious Disease Product Solution and Service
    3.7 Date of Enter into IVD Infectious Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Disease Breakdown Data by Type
    4.1 Global IVD Infectious Disease Historic Market Size by Type (2017-2022)
    4.2 Global IVD Infectious Disease Forecasted Market Size by Type (2023-2028)
5 IVD Infectious Disease Breakdown Data by Application
    5.1 Global IVD Infectious Disease Historic Market Size by Application (2017-2022)
    5.2 Global IVD Infectious Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America IVD Infectious Disease Market Size (2017-2028)
    6.2 North America IVD Infectious Disease Market Size by Type
        6.2.1 North America IVD Infectious Disease Market Size by Type (2017-2022)
        6.2.2 North America IVD Infectious Disease Market Size by Type (2023-2028)
        6.2.3 North America IVD Infectious Disease Market Share by Type (2017-2028)
    6.3 North America IVD Infectious Disease Market Size by Application
        6.3.1 North America IVD Infectious Disease Market Size by Application (2017-2022)
        6.3.2 North America IVD Infectious Disease Market Size by Application (2023-2028)
        6.3.3 North America IVD Infectious Disease Market Share by Application (2017-2028)
    6.4 North America IVD Infectious Disease Market Size by Country
        6.4.1 North America IVD Infectious Disease Market Size by Country (2017-2022)
        6.4.2 North America IVD Infectious Disease Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe IVD Infectious Disease Market Size (2017-2028)
    7.2 Europe IVD Infectious Disease Market Size by Type
        7.2.1 Europe IVD Infectious Disease Market Size by Type (2017-2022)
        7.2.2 Europe IVD Infectious Disease Market Size by Type (2023-2028)
        7.2.3 Europe IVD Infectious Disease Market Share by Type (2017-2028)
    7.3 Europe IVD Infectious Disease Market Size by Application
        7.3.1 Europe IVD Infectious Disease Market Size by Application (2017-2022)
        7.3.2 Europe IVD Infectious Disease Market Size by Application (2023-2028)
        7.3.3 Europe IVD Infectious Disease Market Share by Application (2017-2028)
    7.4 Europe IVD Infectious Disease Market Size by Country
        7.4.1 Europe IVD Infectious Disease Market Size by Country (2017-2022)
        7.4.2 Europe IVD Infectious Disease Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific IVD Infectious Disease Market Size (2017-2028)
    8.2 Asia-Pacific IVD Infectious Disease Market Size by Type
        8.2.1 Asia-Pacific IVD Infectious Disease Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific IVD Infectious Disease Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific IVD Infectious Disease Market Share by Type (2017-2028)
    8.3 Asia-Pacific IVD Infectious Disease Market Size by Application
        8.3.1 Asia-Pacific IVD Infectious Disease Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific IVD Infectious Disease Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific IVD Infectious Disease Market Share by Application (2017-2028)
    8.4 Asia-Pacific IVD Infectious Disease Market Size by Region
        8.4.1 Asia-Pacific IVD Infectious Disease Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific IVD Infectious Disease Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America IVD Infectious Disease Market Size (2017-2028)
    9.2 Latin America IVD Infectious Disease Market Size by Type
        9.2.1 Latin America IVD Infectious Disease Market Size by Type (2017-2022)
        9.2.2 Latin America IVD Infectious Disease Market Size by Type (2023-2028)
        9.2.3 Latin America IVD Infectious Disease Market Share by Type (2017-2028)
    9.3 Latin America IVD Infectious Disease Market Size by Application
        9.3.1 Latin America IVD Infectious Disease Market Size by Application (2017-2022)
        9.3.2 Latin America IVD Infectious Disease Market Size by Application (2023-2028)
        9.3.3 Latin America IVD Infectious Disease Market Share by Application (2017-2028)
    9.4 Latin America IVD Infectious Disease Market Size by Country
        9.4.1 Latin America IVD Infectious Disease Market Size by Country (2017-2022)
        9.4.2 Latin America IVD Infectious Disease Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa IVD Infectious Disease Market Size (2017-2028)
    10.2 Middle East & Africa IVD Infectious Disease Market Size by Type
        10.2.1 Middle East & Africa IVD Infectious Disease Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa IVD Infectious Disease Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa IVD Infectious Disease Market Share by Type (2017-2028)
    10.3 Middle East & Africa IVD Infectious Disease Market Size by Application
        10.3.1 Middle East & Africa IVD Infectious Disease Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa IVD Infectious Disease Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa IVD Infectious Disease Market Share by Application (2017-2028)
    10.4 Middle East & Africa IVD Infectious Disease Market Size by Country
        10.4.1 Middle East & Africa IVD Infectious Disease Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa IVD Infectious Disease Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche Diagnostics
        11.1.1 Roche Diagnostics Company Details
        11.1.2 Roche Diagnostics Business Overview
        11.1.3 Roche Diagnostics IVD Infectious Disease Introduction
        11.1.4 Roche Diagnostics Revenue in IVD Infectious Disease Business (2017-2022)
        11.1.5 Roche Diagnostics Recent Developments
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Details
        11.2.2 Abbott Laboratories Business Overview
        11.2.3 Abbott Laboratories IVD Infectious Disease Introduction
        11.2.4 Abbott Laboratories Revenue in IVD Infectious Disease Business (2017-2022)
        11.2.5 Abbott Laboratories Recent Developments
    11.3 Abbott
        11.3.1 Abbott Company Details
        11.3.2 Abbott Business Overview
        11.3.3 Abbott IVD Infectious Disease Introduction
        11.3.4 Abbott Revenue in IVD Infectious Disease Business (2017-2022)
        11.3.5 Abbott Recent Developments
    11.4 Gen-Probe
        11.4.1 Gen-Probe Company Details
        11.4.2 Gen-Probe Business Overview
        11.4.3 Gen-Probe IVD Infectious Disease Introduction
        11.4.4 Gen-Probe Revenue in IVD Infectious Disease Business (2017-2022)
        11.4.5 Gen-Probe Recent Developments
    11.5 Becton Dickinson (BD)
        11.5.1 Becton Dickinson (BD) Company Details
        11.5.2 Becton Dickinson (BD) Business Overview
        11.5.3 Becton Dickinson (BD) IVD Infectious Disease Introduction
        11.5.4 Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2017-2022)
        11.5.5 Becton Dickinson (BD) Recent Developments
    11.6 Bio-Rad Laboratories
        11.6.1 Bio-Rad Laboratories Company Details
        11.6.2 Bio-Rad Laboratories Business Overview
        11.6.3 Bio-Rad Laboratories IVD Infectious Disease Introduction
        11.6.4 Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2017-2022)
        11.6.5 Bio-Rad Laboratories Recent Developments
    11.7 Siemens Healthcare
        11.7.1 Siemens Healthcare Company Details
        11.7.2 Siemens Healthcare Business Overview
        11.7.3 Siemens Healthcare IVD Infectious Disease Introduction
        11.7.4 Siemens Healthcare Revenue in IVD Infectious Disease Business (2017-2022)
        11.7.5 Siemens Healthcare Recent Developments
    11.8 Biomérieux
        11.8.1 Biomérieux Company Details
        11.8.2 Biomérieux Business Overview
        11.8.3 Biomérieux IVD Infectious Disease Introduction
        11.8.4 Biomérieux Revenue in IVD Infectious Disease Business (2017-2022)
        11.8.5 Biomérieux Recent Developments
    11.9 Danaher
        11.9.1 Danaher Company Details
        11.9.2 Danaher Business Overview
        11.9.3 Danaher IVD Infectious Disease Introduction
        11.9.4 Danaher Revenue in IVD Infectious Disease Business (2017-2022)
        11.9.5 Danaher Recent Developments
    11.10 Thermo Fisher
        11.10.1 Thermo Fisher Company Details
        11.10.2 Thermo Fisher Business Overview
        11.10.3 Thermo Fisher IVD Infectious Disease Introduction
        11.10.4 Thermo Fisher Revenue in IVD Infectious Disease Business (2017-2022)
        11.10.5 Thermo Fisher Recent Developments
    11.11 Sysmex
        11.11.1 Sysmex Company Details
        11.11.2 Sysmex Business Overview
        11.11.3 Sysmex IVD Infectious Disease Introduction
        11.11.4 Sysmex Revenue in IVD Infectious Disease Business (2017-2022)
        11.11.5 Sysmex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global IVD Infectious Disease Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biochemical Diagnosis
    Table 3. Key Players of Immune Diagnosis
    Table 4. Key Players of Molecular Diagnosis
    Table 5. Key Players of Microbiological Diagnosis
    Table 6. Key Players of Urine Diagnosis
    Table 7. Key Players of Coagulation Diagnosis
    Table 8. Key Players of Other
    Table 9. Global IVD Infectious Disease Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 10. Global IVD Infectious Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 11. Global IVD Infectious Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 12. Global IVD Infectious Disease Market Share by Region (2017-2022)
    Table 13. Global IVD Infectious Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 14. Global IVD Infectious Disease Market Share by Region (2023-2028)
    Table 15. IVD Infectious Disease Market Trends
    Table 16. IVD Infectious Disease Market Drivers
    Table 17. IVD Infectious Disease Market Challenges
    Table 18. IVD Infectious Disease Market Restraints
    Table 19. Global IVD Infectious Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 20. Global IVD Infectious Disease Revenue Share by Players (2017-2022)
    Table 21. Global Top IVD Infectious Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2021)
    Table 22. Ranking of Global Top IVD Infectious Disease Companies by Revenue (US$ Million) in 2021
    Table 23. Global 5 Largest Players Market Share by IVD Infectious Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players IVD Infectious Disease Product Solution and Service
    Table 26. Date of Enter into IVD Infectious Disease Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global IVD Infectious Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 29. Global IVD Infectious Disease Revenue Market Share by Type (2017-2022)
    Table 30. Global IVD Infectious Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 31. Global IVD Infectious Disease Revenue Market Share by Type (2023-2028)
    Table 32. Global IVD Infectious Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 33. Global IVD Infectious Disease Revenue Share by Application (2017-2022)
    Table 34. Global IVD Infectious Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 35. Global IVD Infectious Disease Revenue Share by Application (2023-2028)
    Table 36. North America IVD Infectious Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 37. North America IVD Infectious Disease Market Size by Type (2023-2028) & (US$ Million)
    Table 38. North America IVD Infectious Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 39. North America IVD Infectious Disease Market Size by Application (2023-2028) & (US$ Million)
    Table 40. North America IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 41. North America IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Europe IVD Infectious Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 43. Europe IVD Infectious Disease Market Size by Type (2023-2028) & (US$ Million)
    Table 44. Europe IVD Infectious Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 45. Europe IVD Infectious Disease Market Size by Application (2023-2028) & (US$ Million)
    Table 46. Europe IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 47. Europe IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 48. Asia Pacific IVD Infectious Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 49. Asia Pacific IVD Infectious Disease Market Size by Type (2023-2028) & (US$ Million)
    Table 50. Asia Pacific IVD Infectious Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 51. Asia Pacific IVD Infectious Disease Market Size by Application (2023-2028) & (US$ Million)
    Table 52. Asia Pacific IVD Infectious Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 53. Asia Pacific IVD Infectious Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 54. Latin America IVD Infectious Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 55. Latin America IVD Infectious Disease Market Size by Type (2023-2028) & (US$ Million)
    Table 56. Latin America IVD Infectious Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 57. Latin America IVD Infectious Disease Market Size by Application (2023-2028) & (US$ Million)
    Table 58. Latin America IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 59. Latin America IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa IVD Infectious Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa IVD Infectious Disease Market Size by Type (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa IVD Infectious Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa IVD Infectious Disease Market Size by Application (2023-2028) & (US$ Million)
    Table 64. Middle East and Africa IVD Infectious Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 65. Middle East and Africa IVD Infectious Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 66. Roche Diagnostics Company Details
    Table 67. Roche Diagnostics Business Overview
    Table 68. Roche Diagnostics IVD Infectious Disease Product
    Table 69. Roche Diagnostics Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 70. Roche Diagnostics Recent Developments
    Table 71. Abbott Laboratories Company Details
    Table 72. Abbott Laboratories Business Overview
    Table 73. Abbott Laboratories IVD Infectious Disease Product
    Table 74. Abbott Laboratories Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 75. Abbott Laboratories Recent Developments
    Table 76. Abbott Company Details
    Table 77. Abbott Business Overview
    Table 78. Abbott IVD Infectious Disease Product
    Table 79. Abbott Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 80. Abbott Recent Developments
    Table 81. Gen-Probe Company Details
    Table 82. Gen-Probe Business Overview
    Table 83. Gen-Probe IVD Infectious Disease Product
    Table 84. Gen-Probe Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 85. Gen-Probe Recent Developments
    Table 86. Becton Dickinson (BD) Company Details
    Table 87. Becton Dickinson (BD) Business Overview
    Table 88. Becton Dickinson (BD) IVD Infectious Disease Product
    Table 89. Becton Dickinson (BD) Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 90. Becton Dickinson (BD) Recent Developments
    Table 91. Bio-Rad Laboratories Company Details
    Table 92. Bio-Rad Laboratories Business Overview
    Table 93. Bio-Rad Laboratories IVD Infectious Disease Product
    Table 94. Bio-Rad Laboratories Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 95. Bio-Rad Laboratories Recent Developments
    Table 96. Siemens Healthcare Company Details
    Table 97. Siemens Healthcare Business Overview
    Table 98. Siemens Healthcare IVD Infectious Disease Product
    Table 99. Siemens Healthcare Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 100. Siemens Healthcare Recent Developments
    Table 101. Biomérieux Company Details
    Table 102. Biomérieux Business Overview
    Table 103. Biomérieux IVD Infectious Disease Product
    Table 104. Biomérieux Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 105. Biomérieux Recent Developments
    Table 106. Danaher Company Details
    Table 107. Danaher Business Overview
    Table 108. Danaher IVD Infectious Disease Product
    Table 109. Danaher Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 110. Danaher Recent Developments
    Table 111. Thermo Fisher Company Details
    Table 112. Thermo Fisher Business Overview
    Table 113. Thermo Fisher IVD Infectious Disease Product
    Table 114. Thermo Fisher Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 115. Thermo Fisher Recent Developments
    Table 116. Sysmex Company Details
    Table 117. Sysmex Business Overview
    Table 118. Sysmex IVD Infectious Disease Product
    Table 119. Sysmex Revenue in IVD Infectious Disease Business (2017-2022) & (US$ Million)
    Table 120. Sysmex Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global IVD Infectious Disease Market Share by Type: 2021 VS 2028
    Figure 2. Biochemical Diagnosis Features
    Figure 3. Immune Diagnosis Features
    Figure 4. Molecular Diagnosis Features
    Figure 5. Microbiological Diagnosis Features
    Figure 6. Urine Diagnosis Features
    Figure 7. Coagulation Diagnosis Features
    Figure 8. Other Features
    Figure 9. Global IVD Infectious Disease Market Share by Application: 2021 VS 2028
    Figure 10. Personal Case Studies
    Figure 11. Commercial Case Studies
    Figure 12. Academic Case Studies
    Figure 13. Other Case Studies
    Figure 14. IVD Infectious Disease Report Years Considered
    Figure 15. Global IVD Infectious Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 16. Global IVD Infectious Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global IVD Infectious Disease Market Share by Region: 2021 VS 2028
    Figure 18. Global IVD Infectious Disease Market Share by Players in 2021
    Figure 19. Global Top IVD Infectious Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Disease as of 2021)
    Figure 20. The Top 10 and 5 Players Market Share by IVD Infectious Disease Revenue in 2021
    Figure 21. North America IVD Infectious Disease Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. North America IVD Infectious Disease Market Size Market Share by Type (2017-2028)
    Figure 23. North America IVD Infectious Disease Market Size Market Share by Application (2017-2028)
    Figure 24. North America IVD Infectious Disease Market Size Share by Country (2017-2028)
    Figure 25. United States IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Canada IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Europe IVD Infectious Disease Market Size YoY (2017-2028) & (US$ Million)
    Figure 28. Europe IVD Infectious Disease Market Size Market Share by Type (2017-2028)
    Figure 29. Europe IVD Infectious Disease Market Size Market Share by Application (2017-2028)
    Figure 30. Europe IVD Infectious Disease Market Size Share by Country (2017-2028)
    Figure 31. Germany IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. France IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. U.K. IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Italy IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Russia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Nordic Countries IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific IVD Infectious Disease Market Size YoY (2017-2028) & (US$ Million)
    Figure 38. Asia Pacific IVD Infectious Disease Market Size Market Share by Type (2017-2028)
    Figure 39. Asia Pacific IVD Infectious Disease Market Size Market Share by Application (2017-2028)
    Figure 40. Asia Pacific IVD Infectious Disease Market Size Share by Region (2017-2028)
    Figure 41. China IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Japan IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. South Korea IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Southeast Asia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. India IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Australia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 47. Latin America IVD Infectious Disease Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Latin America IVD Infectious Disease Market Size Market Share by Type (2017-2028)
    Figure 49. Latin America IVD Infectious Disease Market Size Market Share by Application (2017-2028)
    Figure 50. Latin America IVD Infectious Disease Market Size Share by Country (2017-2028)
    Figure 51. Mexico IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Brazil IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa IVD Infectious Disease Market Size YoY (2017-2028) & (US$ Million)
    Figure 54. Middle East and Africa IVD Infectious Disease Market Size Market Share by Type (2017-2028)
    Figure 55. Middle East and Africa IVD Infectious Disease Market Size Market Share by Application (2017-2028)
    Figure 56. Middle East and Africa IVD Infectious Disease Market Size Share by Country (2017-2028)
    Figure 57. Turkey IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Saudi Arabia IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. UAE IVD Infectious Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 60. Roche Diagnostics Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 61. Abbott Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 62. Abbott Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 63. Gen-Probe Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 64. Becton Dickinson (BD) Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 65. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 66. Siemens Healthcare Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 67. Biomérieux Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 68. Danaher Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 69. Thermo Fisher Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 70. Sysmex Revenue Growth Rate in IVD Infectious Disease Business (2017-2022)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Diagnostics
Abbott Laboratories
Abbott
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Frequently Asked Questions
IVD Infectious Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
IVD Infectious Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
IVD Infectious Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports